AFP and neoplasm: To explore the CRGs risk model with clinical characteristics, we found that the CRGs signature was associated with multiple clinical features, including alpha-fetoprotein, histological grade, tumor stage, as well as TCGA molecular subtypes, etc. (Figures 7A–N).